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Abstract
Objective Previous research suggests that human baso-
phil activation may be inhibited by histamine even at
extremely low doses (high dilutions). However, uncer-
tainties about the nature of the phenomenon and its
reproducibility mean that further, rigorously controlled
studies are necessary.
Methods Serial 1:100 (v:v) histamine dilutions (centes-
imal dilutions, C) and water controls were tested on human
basophil responsiveness to anti-IgE antibodies, using ﬂow
cytometry. Each dilution step was followed by vertical
mechanical shaking (also designed as succussion) at
20 strokes/s. Basophil-enriched buffy coats from healthy
blood donors were incubated with 10
-4 mol/l histamine
(2C) and with serially diluted preparations from
10
-20 mol/l (10C) to 10
-32 mol/l (16C), then incubated for
30 min with 1 lg/ml goat monoclonal anti-human IgE and
basophils stained for immunophenotyping.
Results Membrane up-regulation of CD203c, which in
these experimental conditions proved to be a more con-
sistent activation marker than CD63, was signiﬁcantly
inhibited in samples treated with histamine at the dilutions
of 2C (P = 0.001), 12C (P = 0.047), 14C (P = 0.003),
15C (P = 0.036) and 16C (P = 0.009). Control water
dilutions/succussions did not show any signiﬁcant effect.
Conclusion Using a strictly standardized ﬂow cytometry
protocol and a new dilution/succussion procedure, we have
shown that low and high dilutions of histamine inhibit
CD203c up-regulation in anti-IgE stimulated basophils.
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Introduction
In the past 20 years, many laboratory studies on cell [1]
and animal [2] models have sought to test the pharmaco-
logical effects of dilutions which statistically contain very
few or no molecules of active principle. The most widely
investigated high-dilution effect has been the regulation of
basophil leukocytes. A prominent multicentre study [3]
found that human basophils underwent ‘‘degranulation’’
(detected as cell metachromasia) not only at the usual anti-
IgE antibody doses (10
-3 mg/ml), but also at extremely
high dilutions of antibody (‘‘sub-molecular’’ doses). This
work was published in the journal ‘‘Nature’’ and had
considerable resonance as a presumed demonstration of
‘‘water memory’’, but was heavily criticized on theoretical
grounds and due to the difﬁculty of reproducing the results
[4–6]. Although this particular model was not followed up
by further replication studies, there has been extensive
research on basophil response to highly diluted substances
focused on the effects of histamine. Several authors report
the inhibition of basophil ‘‘degranulation’’, evaluated by
optical microscopy of cells stained with alcian or toluidine
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concentrations ranging from 10
-10 mol/l (5th centesimal
dilution, 5C) to 10
-38 mol/l (19th centesimal dilution,
19C) [7–9]. The high-dilution effect of histamine has also
been conﬁrmed in a multicentre trial [10], although the
authors report that not all the laboratories involved were
able to observe the phenomenon, possibly due to variations
in basophil sensitivity depending on the donors [11].
Controversies over the manual method used to assess
basophil activation, along with its time-consuming and
subjective nature, prompted adoption of a standardized
automated ﬂow cytometry approach [12], which was able
to evaluate the effect of highly diluted compounds by
quantitatively following membrane expression of the
investigated cells. More recently, similar effects have been
conﬁrmed by two independent laboratories [13, 14] and by
the group of Belon and Sainte-Laudy [15, 16], who also
report that CD203c is the most suitable marker for this type
of effect [17]. However, the literature in this ﬁeld is not
always consistent, with some experiments showing that
highly diluted histamine activates rather than inhibiting the
same cells [18], while another group failed to replicate the
reported inhibitory effects of high histamine dilutions [19].
These last-mentioned authors suggest that minor variables
of the experimental set-up, such as the placement of sam-
ples in different rows on the same laboratory microplate,
may produce signiﬁcant differences in the results if not
properly controlled (though it is worth noting that most
ﬂow cytometry experiments performed by the other authors
were done using disposable tubes). Finally, a number of
studies have used only a 10
-32 mol/l solution (16C) [16],
or a pool of several dilutions [10], but dose–response
curves are rarely reported [13].
Notwithstanding the prevailing evidence in favor of a
true ‘‘high-dilution effect’’, the implausibility of such
claims calls for serious investigation into the possibility of
artifacts, arising from as-yet unidentiﬁed methodological
factors, also because the research in this ﬁeld has until now
failed to account for the discrepancies observed between
different laboratories. Even where many experiments of
high methodological standard have demonstrated an effect
of high dilutions, there has been no positive result stable
enough to be reproduced by all investigators [20–24].
Therefore, given the profound pharmacological and biologi-
cal implications of high-dilution effects, further independent
replications, under rigorously controlled experimental con-
ditions, are needed [25].
Theaimofthisstudywastofurtherinvestigatetheeffects
of histamine on human basophils in vitro, using a new
polychromatic ﬂow cytometry protocol to quantify mem-
brane expression of basophil activation markers [26]. Cell
activation or inhibition were detected by the mean ﬂuores-
cence intensity (MFI) of CD203c, a membrane ectoenzyme
which represents the most sensitive IgE-speciﬁc basophil
activation marker [26–28], and by the percentage of cells
which up-regulatedCD63,amoleculewhich isassociatedto
the lysosomes and is involved in degranulation events [29].
Basophil activation results in a dose-dependent increase in
CD203c MFI,whileexpressionof CD63 isan all-or-nothing
phenomenon which occurs at relatively higher doses of
stimuli and exhibits bimodal distribution [26, 30], with one
peak of highly positive cells (being the FITC ﬂuorochrome
highly ﬂuorescent) and another one of fully negative cells.
This is the reason why most researchers prefer to evaluate
CD63up-regulationnotbytheMFI,butbythepercentageof
cells that express the marker compared to the non-express-
ing resting state [11–16].
Here, we report the results of a series of experiments, in
which particular care was takenwith the following technical
details: (a) to create favorable conditions for the putative
inhibitory effects of histamine, cells were activated using a
relatively low dose of anti-IgE, namely 1 lg/ml [26];
(b) both low (2C) and high (10C to 16C) dilutions of his-
tamine were tested, thus in a range encompassing the
Avogadro constant (6.022 9 10
-23 mol/l); (c) each dilution
step involved a 100 9 decrease in concentration, and was
followed by vigorous mechanical agitation (‘‘succussion’’
according to homeopathic pharmacopoeia) in a shaking
machine commonly used in pharmaceutical practice; (d) all
the assays were performed in triplicate tubes in sterile
conditions and using disposable plasticware to decrease the
risk of cross-contamination; (e) ultrapure distilled water
was used as a solvent, and a series of succussed dilutions of
pure water were run to control for artifacts arising from the
procedures or the materials employed; (f) in order to test the
two main variables, namely CD203c MFI and percentage of
CD63 positive (bright) cells, we used quantitative analyses
and objective evaluations, a procedure that makes per-
forming experiments in blinded fashion less necessary as it
would be when performing the optical detection of basophil
degranulation.
Materials and methods
Reagents and disposable ware
4-(2-Hydroxyethyl)piperazine-1-ethanesulonic acid (HEPES),
sodium heparine 170 U/mg, histamine dihydrochloride,
and salts were purchased from Sigma-Aldrich, GmbH,
Germany. Water used for stock solution and dilutions was
purchased from Sigma-Aldrich as HPLC-grade water
(Chromasolv plus) (\0.001% non-volatile matter). Hista-
mine dihydrochloride was prepared as a stock solution
of 0.4 mol/l in water. Anti-human goat monoclonal IgE
was sourced from Caltag, USA. Anti-CD203c-PE (isotype
756 S. Chirumbolo et al.IgG1, clone 97A6) was purchased from Beckman Coulter
Immunotech, USA, anti-CD123-PECy5 (isotype IgG1,
clone 9F5), anti-HLA-DR-PECy7 (isotype IgG2a, clone
L243), anti-CD45-APCCy7 (isotype IgG1, clone 2D1) and
anti-CD63-FITC (isotype IgG1, clone H5C6) were pur-
chased from Becton Dickinson Pharmingen USA. All
reagents were prepared using sterile disposable plastic
tubes and pipette tips (BD Falcon, NJ, USA).
Dilution and succussion procedures
Dilutions were made up in 15 ml sterile polystyrene con-
ical tubes provided with caps; the serial dilutions were
prepared with an actual histamine concentration four times
greater than the intended ﬁnal concentration, because
the protocol subsequently called for a further fourfold
dilution in the cell incubation mixture (see below). A
4 9 10
-2 mol/l histamine solution (designated 1C) was
made by diluting 500 ll of histamine stock in 4,500 llo f
ultrapure water. From that preparation, a series of incre-
mental 1/100 dilutions were prepared by diluting 50 llo f
the preceding solution in 4,950 ll of ultrapure water and
shaking by vigorous mechanical shaking (7.5 s at
20 strokes/s, vertical amplitude 7 ± 2 mm) using an
instrument from MGA Technologies, Lyon, France. The
chosen working dilutions/succussions were 2C (10
-4 mol/l
histamine in the ﬁnal sample assay) as a positive control,
and seven ultra high dilutions from 10C (10
-20 mol/l his-
tamine in the ﬁnal sample assay) to 16C (10
-32 mol/l
histamine in the ﬁnal sample assay). Experiments with high
water dilutions were performed using control test samples
made up by an identical procedure, with the only difference
that the stock starting solution was pure water rather than
histamine. The histamine and water control dilutions/suc-
cussions were prepared fresh each day just before the
experiments, and stored at room temperature and protected
from light until use.
Cell preparation
Basophil-enriched cell samples were prepared by pooling
the leukocyte buffy coats drawn from 3-ml venous samples
of K2-ethylendiaminotetraacetic acid (EDTA) anti-coagu-
lated peripheral blood of four healthy, non-allergic,
subjects (blood donors). Blood from four different donors
was employed in each separate experiment. All subjects
were informed, by physicians of the Hospital Transfusion
Service, about the use of their blood samples for research
purposes; they completed and signed a speciﬁc consenting
form for taking the samples and data processing. Venous
blood samples were processed within 2–3 h of being
drawn, using a differential centrifugation step procedure.
The blood was diluted to 1:4 in refrigerated (?2C/? 8C)
HEPES modiﬁed buffer ([4-(2-hydroxyethylpiperazine-1-
ethanesulonic acid] 20 mmol/l; NaCl 127 mmol/l; KCl
5 mmol/l; sodium–heparin 5 UI/ml, pH 7.4) using 14-ml
polypropylene round-bottom tubes, and pelleted at 700 g
for 15 min in a (?4C) centrifuge. Leukocyte-rich buffy-
coat layers were individually collected, suspended in the
cold HEPES-heparin (HBE) buffered solution and centri-
fuged at 400 g for 10 min. Pelleted buffy-coats were
washed out from supernatants, collected in a single tube,
suspended in the cold HBE medium and centrifuged at
400 g for a further 10 min. Finally, the cells were sus-
pended in the refrigerated HBE buffer at 1:4 v/v relative to
starting whole blood volume. An aliquot of about 1 ml of
the above HBE-suspended cell culture was transferred to a
Bayer ADVIA 2120 automated hematocytometer [31] for
basophil counting and yield evaluation. Pooled buffy coats
having a mean count of 8.47 ± 2.09 SD WBCx103/ll and
an estimated basophil concentration of 92.25 ± 18.43 SD
cells/ll, were obtained. This yield corresponded to an
enrichment of approximately 2.4 times relative to the
starting whole blood [26]. Cells were treated with apyro-
genic solutions and using sterile disposable plastic ware,
and kept on ice to prevent any spontaneous activation [30].
Just before use, the cell suspension was pre-warmed for
10 min at 37C and gently mixed.
Cell treatment and activation
A volume of 50 ll of the histamine or water dilutions was
added to 5-ml round bottomed polypropylene vials con-
taining 50 llo f29 concentrated HBE buffer (test tubes
series ‘‘A’’) and warmed at 37C for 10 min. Then 100 ll
of the cell suspensions was added to each vial and incu-
bated for 10 min at 37C. A parallel series of 5 ml-round
bottomed polystyrene vials were prepared, each containing
50 ll of an HBE solution supplemented with 5 mM CaCl2,
1 mM MgCl2 and with the anti-IgE agonist, where indi-
cated (ﬁnal concentration 1 lg/ml) (test tubes series ‘‘B’’).
After the 10-min incubation with histamine dilutions, 50 ll
of the cell suspensions from test tube series ‘‘A’’ was added
into those of series ‘‘B’’, previously brought to 37C.
Incubation with and without anti-IgE was carried out at
37C for 30 min; the tubes were gently stirred every
10 min to allow proper mixing. The incubation was halted
by adding 100 ll of ice-cold HBE buffer supplemented
with 2.8 mmol/l Na3-EDTA, and the samples put on
ice until staining with monoclonal antibodies. We only
included experiments that met the following criteria:
(a) signiﬁcant cell activation following anti-IgE treatment,
expressed as a statistically signiﬁcant increase of 203c MFI
in triplicate samples of anti-IgE treated cells as compared
with triplicate samples of untreated, resting cells and,
(b) inhibition induced by histamine 2C[50% as compared
Inhibition of CD203c membrane up-regulation in human basophils 757with cell samples activated in the absence of histamine
[17]. Applying these criteria, ﬁve of the seven experiments
performed with histamine dilutions and ﬁve of the six
experiments performed with water dilutions were selected
as valid.
Staining with monoclonal antibodies and sample
analysis
Staining was performed at 4C for 20 min with
10 ll/200 ll cell suspensions of the marker antibodies
Anti-CD203c-PE, anti-CD123-PECy5, anti-CD63-FITC
and with 5 ll/200 ll cell suspensions of the marker
antibodies CD45-APCCy7 and HLA-DR-PECy7. The
negative controls consisted of isotype matched, directly
conjugated non-speciﬁc antibodies. Soon after staining,
samples underwent erythrocyte lysis with 3 ml of a
?4C refrigerated ammonium-chloride solution (NH4Cl
155 mmol/l; NaHCO3 10 mmol/l, Na3EDTA 0.10 mmol/
l, pH = 7.2) for 2 min on ice, after which the cells
were pelleted at 500 g for 5 min in a refrigerated cen-
trifuge. Supernatants were removed and the pellets gently
suspended in 0.5 ml of a BD-Isoﬂow phoshpate saline
(PBS, pH = 7.4) balanced buffer. Flow analysis was
performed using a 488–633 nm two-laser ﬂow cytometer
(BD FACScanto). A region of low side-scatter cells was
gated in the CD45
dim lymphocyte area; in this region
about 500 (450–550) cellular events from each sample
with a HLADR
non-expressing/CD123
bright phenotype were
identiﬁed as basophils [26, 32]. The threshold between
CD63
non-expressing and CD63
expressing basophils was arbi-
trarily set in each experiment close to the right-hand
limit of the ﬂuorescence peak of a sample of unstimu-
lated, untreated cells. The MFI was calculated by the
cytometer software by averaging the total ﬂuorescence of
the marker in the basophil gate.
Statistics
The observed MFI values for each experiment were
recorded, and exploratory statistics such as the average and
standard deviation were computed. Normality was checked
by the Shapiro–Wilk test. The symmetry of the data was
also tested, showing our experimental MFI values to be
strongly right-skewed. In light of the non-symmetrical
distribution of the data, which clearly did not satisfy the
assumption of normality, it was decided to use non-para-
metric tests. Since ANOVA was unsuitable due to non-
normality, for the global analysis of all the treatments, we
adopted the Friedman non-parametric test for multiple-
related samples. For the comparison between control and
treatment groups, we applied the two-tailed Wilcoxon non-
parametric test for paired samples. The data were ﬁrst of all
paired by experiment: since we had three different results
within each experiment, we compared the lower, the mid-
dle and the upper value of the control group with the
corresponding value of the treated group. We then took all
the 15 values from the ﬁve experiments on each treatment
group and compared them with all the 15 values from the
control (no histamine) group. Since the CD203c is consti-
tutively expressed at low level in resting, unstimulated
basophils, the net activation response to anti-IgE (dMFI)
was calculated by subtracting the mean resting ﬂuores-
cence expressed by unstimulated cells in each experiment
from the ﬂuorescence values of anti-IgE activated samples.
Then, the percentage inhibitory effect of each dilution on
the cell activation to the anti-IgE was calculated, for each
experiment, according to the formula:
The level of signiﬁcance was set at P\0.05.
Results
Figure 1 shows a typical dot plot of basophil immunologic
phenotyping and electronic capture. The HLADR-PECy7/
CD123-PECy5 plot, constructed using the CD45-dim cells
in the lymphocyte area (see Sect. ‘‘Materials and meth-
ods’’), made it possible to deﬁne a clearly delimited area of
CD123
bright cells not expressing HLADR, which can be
identiﬁed as basophils (Fig. 1a). Basophil response toward
the agonist was initially examined by evaluating two-
parameter dot plots of the acquired events (Fig. 1b, c).
Non-activated (resting) basophils (Fig. 1b, panel C) typi-
cally showed a very low CD63 ﬂuorescence (MFI from 0 to
10
3 units) and a low level of CD203c ﬂuorescence (MFI
from 3 9 10
2 to 3 9 10
3 units). Following 30 min of
incubation with 1 lg/ml anti-IgE, only a small fraction of
cells (from 3 to 15% of total basophils in the entire series
of experiments) showed a CD63 bright phenotype (Fig. 1c,
panels A and B), while between 60 and 80% of basophils
up-regulated CD203c membrane expression (Fig. 1c, pan-
els C and D). From these two-parameter dot plots, a large
Mean dMFI of control no histamine ðÞ   dMFI of histamine   treated sample
Mean dMFI of control no histamine ðÞ
  100
758 S. Chirumbolo et al.population of activated basophils expressing a CD203c
bright
phenotype was clearly evident, while most of these acti-
vated cells were negative at the CD63 staining. This
conﬁrms that CD203c is a more suitable type of marker for
this type of study [17, 28], particularly when the extent of
activation is low [26].
Table 1 reports the data of ﬁve experiments, each one
done in triplicate, where basophil samples were activated
in the absence and in the presence of histamine at
increasing dilutions. Activation of basophils with anti-IgE
caused a considerable increase in the MFI of CD203c
compared with unstimulated cells (from a mean of 1812.4
units to a mean of 4389.0 units in the series of ﬁve
experiments). The complete series of 15 replicates was
analyzed using non-parametric tests since the distribution
of values was not normal. Histamine 2C (positive control)
reduced the response to 2781.7 MFI units (P = 0.001).
A global analysis using the Friedman test for multiple
samples indicated that the differences between control
samples (no histamine) and the series of samples treated
with the high dilutions of histamine were statistically sig-
niﬁcant (P = 0.012), even excluding the 2C test solution
which was the obvious positive control in this series. The
two-sample comparison with control revealed signiﬁcant
inhibitions of CD203c up-regulation following incubation
with histamine 12C (P = 0.047), 14C (P = 0.003), 15C
(P = 0.036), 16C (P = 0.009); with histamine 13C the
difference was not signiﬁcant but very close to the limit
value (P = 0.061).
Table 1 shows the results of ﬁve separate experiments in
which succussed high dilutions of histamine were replaced
with succussed high dilutions of water. For technical rea-
sons due to the high number of tested dilutions and of
replicates and in order to maintain high analytical accu-
racy, we could not test all histamine dilutions and all water
dilutions in the same cells, so the two series of experiments
reported in Table 1 were done in separate sequences, but
using exactly the same protocol and the same water batch.
The response of control, uninhibited samples to anti-IgE
shifted from a mean of 1552.2 units to a mean of 5694.3
units and histamine 2C dilution (positive control for inhi-
bition) reduced CD203c expression to 3252.9 MFI units
(P = 0.001), showing that the cells were fully sensitive to
histamine, as well as the ﬁrst series reported in Table 1.
However, none of the water succussed dilutions showed
any signiﬁcant effect on the test system in two-sample
comparisons with uninhibited, anti-IgE-activated sample.
The Friedman test for the control and high dilutions, with
the histamine 2C sample (positive control) omitted from
the analysis, was negative (P = 0.590).
Table 2 shows the percentage of CD63
expressing cells.
These data are from the same cell samples tested for
CD203c MFI and reported in Table 1. The percentage
of spontaneous activation (no anti-IgE) was very low
Fig. 1 Human basophil gating
with the BD-FACScanto ﬂow
cytometer. In a leukocytes are
immunologically gated in the
CD45
dim-lymphocyte area and
electronically captured as
cellular events in HLADR
non-
expressing/CD123
bright two-
parameter plot to distinguish
them from monocytes (Q1),
plasmacytoid dendritic cells
(Q2) and lymphocytes (Q3). Dot
plots b and c show CD63/
CD203c expression in resting
and anti-IgE-activated human
basophils, respectively. The
cloud of resting CD203c
low
expressing/CD63
negative cells (area
C in b) shifts to the right upon
activation (c), but only a small
percentage of cells express
CD63 (area B in c)
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760 S. Chirumbolo et al.(1.07–1.81% in histamine and water experiments, respec-
tively), indicating that the isolation procedure yielded a
basophil preparation at resting state and close to physio-
logical conditions. Following challenge with anti-IgE, the
CD63
expressing cells increased to 8.22% in the series of
experiments testing high histamine dilutions (2a), and to
15.87% in the series of experiments testing high water
dilutions (2b). This difference between these two series of
experiments, in the basophil response to anti-IgE could be
explained by the very low expression of CD63 in our
experimental conditions (see also Fig. 1), which is asso-
ciated with high variability of data. A further factor of
variability could be related to high inter-individual differ-
ences of basophil responsiveness, possibly due to seasonal
variations or previous contacts with sensitizing substances,
previously noted by others [27, 33], which may be reduced
but not completely eliminated by pooling buffy-coats from
different donors. Anymore, also with this marker all the
cells tested were strongly inhibited by histamine at low
dilution (2C), which decreased the CD63
expressing cells to
4.20% (Table 2) and to 7.31% (Table 2)( P = 0.008 and
0.001, respectively). A few high histamine dilutions also
decreased the percentage of CD63
expressing cells (e.g. 13C,
14C, 15C, 16C), but because of high variation of values
this effect was not statistically signiﬁcant (borderline for
histamine 14C). No effects were determined by highly
diluted water and succussed solutions.
Figure 2 reports the percentage inhibition by histamine
and control water across the range of high dilutions tested
on CD203c expression (MFI). Preliminary experiments
showed that histamine (low and high dilutions) did not
affect the resting MFI but only the activation response. So
the percentage effect was calculated not on the absolute
values, but only on the net MFI after subtracting the resting
MFI. Histamine 2C (positive control) inhibition was
60.91% (P\0.01) and 59.43% (P\0.01) in the experi-
ments testing histamine and water dilutions, respectively.
There was no signiﬁcant difference between the inhibition
by histamine 2C in the two series. The dilution–effect
histogram of histamine (A) shows a non-linear behaviour,
with peaks at 14C and 16C dilution and paradoxically less
activity at lower dilutions. No signiﬁcant effects of water
control dilutions (B) were observed.
Discussion
Human basophils are peripheral granulocytes involved in
immune and inﬂammatory processes such as hypersensitiv-
ity and allergic reactions. The discovery of several basophil
activation markers, such as the tetraspanin CD63 (lyso-
some-associated membrane protein or LAMP-3) and the
ectoenzyme CD203c (or ecto-nucleotide pyrophosphatase/
phosphodiesteraseorE-NPP3),hasmadeitpossibletostudy
cellular function by observing the up-regulation or down-
regulation of membrane molecules in response to various
physiological agonists, antagonists or other soluble regula-
tors [34, 35], using a standardized cytometric approach.
Among the various soluble factors able to regulate
basophil function, a considerable body of literature has
been devoted to histamine, a well-known mediator of
inﬂammation produced by basophils and mast cells. His-
tamine at high doses acts as a downstream regulator by
Fig. 2 Percentage inhibition of anti-IgE-activated CD203c expres-
sion in human basophils treated with high histamine dilutions (a)o r
with high water dilutions (b). Mean ± SEM percentages from ﬁve
experiments in (a) and from ﬁve experiments in (b) were calculated
after subtracting the constitutive ﬂuorescence of resting cells from the
ﬂuorescence of anti-IgE-activated cells, as described in ‘‘Materials
and methods’’. *P\0.05, **P\0.01 (two-tailed Wilcoxon test for
paired data, comparing histamine or water dilutions with the mean of
untreated controls in each experiment). CD203c MFI values of the
uninhibited activation were 2576.6 ± 543.3 SEM in the histamine
dilution experiments (a) and 4142.1 ± 348.4 SEM in the water
dilution experiments (b)
Inhibition of CD203c membrane up-regulation in human basophils 761interacting with H2-receptors, thus inhibiting basophil
release of mediators and degranulation [36]; it is therefore
very intriguing that the same effect was observed with
highly diluted histamine but not with highly diluted histi-
dine [11], and that it could be inhibited by the H2-
antagonist cimetidine [37]. Multicentre analyses have
partially conﬁrmed these ﬁndings [10], but other groups
also report some negative results [19].
In this work we were able to reproduce evidence for the
effects of high histamine dilutions on anti-IgE-triggered
basophil activation, speciﬁcally evaluated by the CD203
MFI, using a standardized approach with the following
characteristics: (a) the method of cell handling prevents
spontaneous basophil activation and interference between
the anti-IgE-FITC tracer and the agonist used [14]; (b) the
problems of subjective evaluation are avoided through use
of ﬂow cytometry and a system of multiple intra-series
replication; (c) use of highly pure compounds and parallel
comparisons with control pure water dilutions; d) adoption,
for the ﬁrst time in this ﬁeld, of a mechanical shaking
method (succussion in homeopathic terms) with standard-
ized duration and frequency of strokes.
The resultant dose–effect curve displayed a very unusual
behaviour, whose underlying mechanism remains to be
investigated. It is worth noting that the range of active
dilutions is very close to the 16C dilution reported else-
where [11, 15], although Brown and Ennis [13] instead
reported inhibitory activities for 10C and 13C, but not for
the 12C, 14C and 16C dilutions.
The lack of signiﬁcant inhibition of CD63 expression by
histamine at high dilutions in our experimental conditions
(Table 2) may apparently be in disagreement with the data
of CD203c and with the ﬁndings of other authors who
detected high-dilution effects also using CD63 marker [11].
However, this discrepancy may be interpreted as due to the
lower sensitivity of this parameter to inhibition by high
dilutions or otherwise as a result of the high variability of
this response, because of the low percentage of cells
expressing CD63 in our test system. In this study we chose
to use low doses of agonist, a condition in which cells were
consistently activated, as noted by the increase of CD203c
MFI, but very low percentage (8–15%) of cells expressed
CD63, which is less responsive to low doses of anti-IgE
(Fig. 1a). As a consequence, the high-dilution effects were
much more clearly and consistently observable by evalu-
ating the CD203c marker. We have previously shown that
the chemotactic peptide fMLP, at very low dose, causes up-
regulation of CD203c but not of CD63 [26], and this
observation is consistent with the ﬁnding that CD203c
reﬂects the priming events triggered by interleukin-3,
which occur previously to degranulation events [28].
Moreover, CD203c expression in not inhibited by phos-
phatidylinositol-3-kinase inhibitors, as is CD63 [29]. Thus,
small changes in the experimental conditions used or subtle
distinction of the signal transduction mechanisms of the
two markers expression could differentiate the results of
high dilution experiments obtained by different authors in
this model.
Although a variety of gating protocols and different
experimental conditions—in terms of the type of dilution/
succussion or shaking procedures and solvent used—have
been explored [13, 38], most of the studies done so far did
not include succussed water controls. Research on extre-
mely sensitive systems and very high dilutions of
substances suggests that trace elements, as well as con-
tainer materials, storage durations and shaking methods,
may inﬂuence the results [39]. Therefore, suitable water
controls prepared in an identical manner and subjected to
the same storage time should be used. These consider-
ations, coupled with the highly controversial nature of the
phenomenon, which would have signiﬁcant pharmacolog-
ical implications but is often judged to be improbable and
implausible from a conventional scientiﬁc perspective [24,
40, 41], make it all the more important that more replica-
tions should be done independently to establish models that
are stable across laboratories and teams [22].
The possible biological mechanism(s) underlying the
regulatory processes affected by high histamine dilutions
remain to be elucidated. These ﬁndings suggest that the
high dilutions of histamine, which are better observed
through CD203c expression, might affect some subtle and
early level of signal transduction, similar to the priming
effects of very low doses, instead of causing a general
inhibition of cell responses. Using a surface plasmon res-
onance biosensor, it has recently been shown that basophil
activation by anti-IgE, even in the absence of exocytosis, is
associated with changes in the refractive index of the
evanescent ﬁeld [42]; such changes reﬂect any changes in
molecular mass distribution in the ﬁeld a few 100 nm from
the surface of the cells. It is thus tempting to speculate that
changes in the water structure produced by the dilution/
succussion procedure in the presence of histamine might
inﬂuence this crucial layer of water surrounding the cell
and hence the processes of signal detection and transduc-
tion. Further studies are needed to conﬁrm whether this
hypothesis is applicable to the high-dilution effects
observed on human basophils.
Our results conﬁrm and build upon the hypothesis that
high dilutions of biologically active compounds may indeed
have an effect which mimics that of lower dilutions/higher
doses. So far there is no satisfactory or uniting theoretical
explanation for these observations, but recent evidence
seems to point to organization of the solvent water on a
mesoscopic scale: the nano-heterogenous structure of water
can be determined by interactive phenomena such as
coherence [43, 44], epitaxy [45], temperature–pressure
762 S. Chirumbolo et al.processes during strong agitation, and formation of colloi-
dal nanobubbles containing gaseous inclusions of oxygen,
nitrogen, carbon dioxide, silica, and possibly the remedy
source material [46–48]. So far, nuclear magnetic resonance
(NMR) studies of homeopathic solutions have yielded
controversial data, but recently high histamine dilutions
(beyond 10
-20 mol/l) were distinguished from water sol-
vents on the basis of their NMR relaxation rates [49];
moreover, after heating of the histamine samples, all the
relaxation observed as a function of dilution vanished. It
was suggested that histamine molecules might act as
nucleation centres, amplifying the formation of stable
supramolecular structures, involving nanobubbles of
atmospheric gases and highly ordered water aroundthem. In
the future, the possible existence and the nature of clathrate-
like hydrate nanostructures formed during the dilution and
succussion process might be explained by cluster science, in
which different geometrical structures of clusters composed
of the same chemical species may differ in their chemical
reactivity [50]. These unusual properties of high dilutions,
which merit further investigation, are potentially relevant
not just to homeopathic pharmaceutical practice, but also to
basic research into cell sensitivity to regulation.
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